Recent evidence that supports the suppression of PTGS1 was also demonstrated to exhibit anticancer properties, including HCC (Gupta et al., 2003; Cusimano et al., 2007; Cho et al., 2013). The gene discussed is PTGS1; the disease is hepatocellular carcinoma.